Sarah Boyce
2020 - Avidity Biosciences
In 2020, Sarah Boyce earned a total compensation of $823.1K as President and Chief Executive Officer at Avidity Biosciences, a 82% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $338,000 |
|---|---|
| Salary | $484,256 |
| Other | $837 |
| Total | $823,093 |
Boyce received $484.3K in salary, accounting for 59% of the total pay in 2020.
Boyce also received $338K in non-equity incentive plan and $837 in other compensation.
Rankings
In 2020, Sarah Boyce's compensation ranked 9,392nd out of 13,090 executives tracked by ExecPay. In other words, Boyce earned more than 28.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,392 out of 13,090 | 28th |
Division Manufacturing | 4,018 out of 5,620 | 29th |
Major group Chemicals And Allied Products | 1,634 out of 2,253 | 28th |
Industry group Drugs | 1,430 out of 1,953 | 27th |
Industry Pharmaceutical Preparations | 1,051 out of 1,458 | 28th |
Source: SEC filing on April 29, 2021.
Boyce's colleagues
We found two more compensation records of executives who worked with Sarah Boyce at Avidity Biosciences in 2020.